Who owns Nektar Therapeutics?

Key details on Nektar Therapeutics (Ticker: NKTR)

Who owns Nektar Therapeutics?

Is NKTR a good stock to own? Find out who bought Nektar Therapeutics, who sold Nektar Therapeutics (NKTR) stock, and who holds a large position in Nektar Therapeutics.

Fund Name Number of Shares Share Valuation As Of
OppenheimerFunds 24.40M $295.73M March 31, 2014
PRIMECAP Management Company 15.53M $188.27M March 31, 2014
HealthCor Management 9.20M $66.88M June 30, 2011
Vanguard 8.15M $98.74M March 31, 2014
Federated Investors 6.38M $77.37M March 31, 2014
Ulys 5.17M $28.93M Dec. 31, 2011
BlackRock Fund Advisors 4.86M $58.95M March 31, 2014
JPMORGAN CHASE & CO 4.54M $55.07M March 31, 2014
First Trust Advisors 4.46M $54.05M March 31, 2014
STATE STREET CORPORATION 4.20M $50.85M March 31, 2014
HealthCor Management 4.00M $46.20M June 30, 2013
GRANAHAN INVESTMENT MANAGEMENT INC/MA 3.67M $47.10M June 30, 2014
BlackRock Institutional Trust Company, N.A. 3.56M $43.18M March 31, 2014
Franklin Resources 3.04M $36.89M March 31, 2014
Deerfield Management Company 2.94M $33.95M June 30, 2013
Invus Public Equities Advisors 2.75M $19.99M June 30, 2011
BVF 2.73M $20.26M Dec. 31, 2012
Barclays 2.71M $21.48M March 31, 2012
Artal Group S.A. 2.30M $24.04M Sept. 30, 2013
Tang Capital Management 2.20M $23.50M Sept. 30, 2012
NEA Management Company 1.83M $23.40M June 30, 2014
Inves 1.77M $21.51M March 31, 2014
Millennium Management 1.73M $18.99M March 31, 2013
SYSTEMATIC FINANCIAL MANAGEMENT 1.67M $17.45M Sept. 30, 2013
Legg Mason Capital Management 1.67M $13.23M March 31, 2012
NORTHERN TRUST 1.67M $18.94M Dec. 31, 2013

Who sold Nektar Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management Dec. 31, 2010 3.49M $44.80M
Tudor Investment Corporation Dec. 31, 2005 1.72M $28.26M
Maverick Capital Dec. 31, 2004 2.47M $50.04M